NASDAQ : ALMS
Alumis Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 6.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 871.10M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 871.10M |
| Enterprise Value | 405.23M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 129.44M |
| Shares Outstanding | 129.44M |
| Shares Change (YoY) | +92.96% |
| Shares Change (QoQ) | +2.11% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 67.81% |
| Float | 91.34M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 117.75 |
| Forward PS | 198.98 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 54.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 6.74 |
| Quick Ratio | 6.64 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -93.65% |
| Return on Assets (ROA) | -45.34% |
| Return on Invested Capital (ROIC) | -52.46% |
| Return on Capital Employed (ROCE) | -87.74% |
| Weighted Average Cost of Capital (WACC) | 2.16% |
| Revenue Per Employee | $30,954 |
| Profits Per Employee | -$1.84M |
| Employee Count | 239 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.76M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.36 |
| 52-Week Price Change | +42.89% |
| 50-Day Moving Average | 9.86 |
| 200-Day Moving Average | 21.42 |
| Relative Strength Index (RSI) | 37.35 |
| Average Volume (20 Days) | 2,093,513 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11.08M |
| Short Previous Month | 10.30M |
| Short % of Shares Out | 8.56% |
| Short % of Float | 12.13% |
| Short Ratio (days to cover) | 4.15 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 7.40M |
| Gross Profit | 7.40M |
| Operating Income | -424.98M |
| Pretax Income | -440.71M |
| Net Income | -438.96M |
| EBITDA | -421.45M |
| EBIT | -424.98M |
| Loss Per Share | -$3.80 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 502.29M |
| Total Debt | 36.43M |
| Net Cash | 465.87M |
| Net Cash Per Share | $3.60 |
| Equity (Book Value) | 452.16M |
| Book Value Per Share | 3.52 |
| Working Capital | 437.85M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -351.40M |
| Capital Expenditures | -401,000 |
| Depreciation & Amortization | 3.53M |
| Net Borrowing | n/a |
| Free Cash Flow | -351.80M |
| FCF Per Share | -$2.72 |
Margins
| Measure | Value |
|---|
| Gross Margin | 100.00% |
| Operating Margin | -5,744.49% |
| Pretax Margin | -5,957.20% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -92.96% |
| Shareholder Yield | -92.96% |
| Earnings Yield | -56.47% |
| FCF Yield | -40.39% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $31.13 |
| Price Target Difference | 362.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 86.63% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.38 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |